| Dr Sherwood M Chetlin, MD | |
|
3500 5th Ave, Arthritis And Internal Medicine, Pittsburgh, PA 15213-3337 | |
| (412) 682-2434 | |
| (412) 682-1044 |
| Full Name | Dr Sherwood M Chetlin |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 3500 5th Ave, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356341937 | NPI | - | NPPES |
| 0006916430005 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD014712E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sherwood M Chetlin, MD 3500 5th Ave, Arthritis And Internal Medicine, Pittsburgh, PA 15213-3337 Ph: (412) 682-2434 | Dr Sherwood M Chetlin, MD 3500 5th Ave, Arthritis And Internal Medicine, Pittsburgh, PA 15213-3337 Ph: (412) 682-2434 |
News Archive
An article published today in the American Journal of Obstetrics and Gynecology reports that a commonly-used drug for the treatment of diabetes, metformin, may have the potential to prevent and treat preeclampsia. Metformin has long been used to treat diabetes in both non-pregnant and pregnant patients, and is considered safe during pregnancy.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that it has filed a clinical trial application (CTA) with the European Medicines and Healthcare products Regulatory Agency (MHRA) seeking clearance to initiate its Phase 1/2 clinical trial using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD).
Childhood trauma is known to increase the risk of post-traumatic stress disorder in adulthood, especially for women, but the biological reasons for this correlation remain largely unknown.
Scientists have shown in the laboratory that metal nanoparticles damaged the DNA in cells on the other side of a cellular barrier. The nanoparticles did not cause the damage by passing through the barrier, but generated signalling molecules within the barrier cells that were then transmitted to cause damage in cells the other side of the barrier.
› Verified 5 days ago
Krishna Kancharla, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5200 Centre Ave, Suite 710, Pittsburgh, PA 15232 Phone: 412-623-6889 | |
Christine Peoples, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3601 5th Ave, Suite 3b Falk Medical Building, Pittsburgh, PA 15213 Phone: 412-647-6700 | |
Rima Abdel Massih, Rheumatology Medicare: Medicare Enrolled Practice Location: 3601 5th Ave, Suite 3a, Pittsburgh, PA 15213 Phone: 412-648-6273 | |
Dr. Matthew Michael Lander, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 320 E North Ave, Pittsburgh, PA 15212 Phone: 412-359-6500 | |
Allie Dakroub, MD MS Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 200 Lothrop Street, Suite 9 South, Pittsburgh, PA 15213 Phone: 412-692-4888 | |
Katrina Han, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3601 5th Ave Bldg Suite3a, Pittsburgh, PA 15213 Phone: 412-586-9700 | |
Omar Khaled Osman, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1307 Federal St Ste B300, Pittsburgh, PA 15212 Phone: 412-359-3751 |